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Abstract
Objectives To estimate the cost effectiveness of alternative planned
places of birth.
Design Economic evaluation with individual level data from the Birthplace
national prospective cohort study.
Setting 142 of 147 trusts providing home birth services, 53 of 56
freestanding midwifery units, 43 of 51 alongside midwifery units, and a
random sample of 36 of 180 obstetric units, stratified by unit size and
geographical region, in England, over varying periods of time within the
study period 1 April 2008 to 30 April 2010.
Participants 64 538 women at low risk of complications before the onset
of labour.
Interventions Planned birth in four alternative settings: at home, in
freestanding midwifery units, in alongside midwifery units, and in obstetric
units.
Main outcome measures Incremental cost per adverse perinatal
outcome avoided, adverse maternal morbidity avoided, and additional
normal birth. The non-parametric bootstrap method was used to generate
net monetary benefits and construct cost effectiveness acceptability
curves at alternative thresholds for cost effectiveness.
Results The total unadjusted mean costs were £1066, £1435, £1461,
and £1631 for births planned at home, in freestanding midwifery units,
in alongside midwifery units, and in obstetric units, respectively
(equivalent to about €1274, $1701; €1715, $2290; €1747, $2332; and
€1950, $2603). Overall, and for multiparous women, planned birth at
home generated the greatest mean net benefit with a 100% probability
of being the optimal setting across all thresholds of cost effectiveness
when perinatal outcomes were considered. There was, however, an
increased incidence of adverse perinatal outcome associated with
planned birth at home in nulliparous low risk women, resulting in the
probability of it being the most cost effective option at a cost effectiveness
threshold of £20 000 declining to 0.63. With regards to maternal
outcomes in nulliparous and multiparous women, planned birth at home
generated the greatest mean net benefit with a 100% probability of being
the optimal setting across all thresholds of cost effectiveness.
Conclusions For multiparous women at low risk of complications,
planned birth at home was the most cost effective option. For nulliparous
low risk women, planned birth at home is still likely to be the most cost
effective option but is associated with an increase in adverse perinatal
outcomes.
Introduction
Since the early 1990s, government policy on maternity care in
England has moved towards policies designed to give women
withstraightforwardpregnanciesachoiceofsettingsforbirth.
1 2
In this context, freestanding midwifery units, midwifery units
located in the same building or on the same site as an obstetric
unit (hereafter referred to as alongside midwifery units), and
home birth services have increasingly become relevant to the
configuration of maternity services under consideration in
England.
3 The relative benefits and risks of birth in these
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Research
RESEARCHalternative settings have been widely debated in recent years.
4-10
Lowerratesofobstetricinterventionsandotherpositivematernal
outcomes have been consistently found in planned births at
home and in midwifery units, but clear conclusions regarding
perinataloutcomehavebeenlacking.Moreover,robustevidence
on the cost effectiveness of birth in alternative settings is a
priority, as was highlighted by the recent National Institute for
Health and Clinical Excellence (NICE) clinical guidance on
intrapartum care.
11 The Birthplace in England research
programmewasdesignedtofillgapsinresearchevidenceabout
the processes and outcomes associated with different settings
for birth in the NHS in England. The results of the safety
outcomes generated by the Birthplace in England national
prospective cohort study (hereafter referred to as the cohort
study) are reported elsewhere.
12 We report on the cost
effectiveness of alternative planned places of birth based on
data collected by the research programme.
Methods
Study population
The study population included all “low risk” women who
participated in the cohort study, as described elsewhere.
12 In
brief, the cohort study was designed to compare outcomes in
women judged to be at low risk of complications before the
onset of labour. Outcomes were compared by planned place of
birth: at home, in freestanding midwifery units, in alongside
midwifery units, or in obstetric units. The cohort study aimed
tocollectdataineveryNHStrustinEnglandthatprovideshome
birth services, every free standing midwifery unit, every
alongside midwifery unit, and a random sample of obstetric
units, stratified by unit size and geographical region, over
varying periods of time within the study period (1 April 2008
to 31 April 2010). The target sample size was at least 57 000
women: 17 000 planned home births, 5000 planned births in
freestandingmidwiferyunits,5000plannedbirthsinalongside
midwifery units, and 30 000 planned births in obstetric units,
ofwhichweestimated20000wouldbelowrisk.Thedefinition
of low risk used in the cohort study was based on criteria
contained in the NICE Intrapartum Care Guidelines.
11 The
primary clinical outcome was a composite measure of adverse
perinatal outcomes encompassing perinatal mortality and
specifiedneonatalmorbidities(box).Otheroutcomesconsidered
were adverse maternal morbidity and “normal birth” (box).
Further design details for the cohort study, including the
eligibility criteria, sample size calculations, derivation of risk
status, outcome measures, and ethical procedures, are reported
elsewhere.
13
Type of economic evaluation, study
perspective, and time horizon
The economic evaluation took the form of a cost effectiveness
analysis in which we estimated the incremental costs (ΔC) and
incremental effects (ΔE) attributable to planned birth at home,
in a free standing midwifery unit, or in an alongside midwifery
unit, with reference to planned birth in an obstetric unit, and
expressed each in terms of an incremental cost effectiveness
ratio (ICER; ΔC/ΔE). The obstetric unit group contained the
largest number of eligible births and was therefore used as the
reference to maximise statistical efficiency. Estimates of cost
effectiveness were made for the primary clinical
outcome—adverse perinatal outcome—and for two secondary
outcomes—namely, adverse maternal morbidity and normal
birth. The economic evaluation was conducted from a health
system perspective and consequently we have included only
direct costs to the NHS.
15 The time horizon primarily mirrored
the duration of follow-up of the cohort study, which identified
women at the start of their care in labour and was completed
when the intrapartum and immediate after birth care for both
mother and baby ended, be it at home or at discharge from a
midwifery unit or hospital. If higher level care after the birth
was required for the mother or the baby, or both, this was
included in the economic evaluation.
Measurement of resource use
Individual data collection forms, designed as part of the cohort
study, documented duration of labour, mode of delivery, some
forms of pain relief, active management of the third stage of
labour, whether an episiotomy was performed, clinical
complications, length of stay for both mother and baby by type
of ward and level of care, and transfers by duration and mode.
Toestimateadditionalresourceusenotcapturedonanindividual
level in the cohort study, we developed supplemental data
collection forms after five focus groups held with midwives
fromallpartsofEnglandearlyintheproject.Theseformswere
designed to capture the pathways of care experienced by
individual women progressing through the stages of labour and
care after birth and their associated resource inputs. For the
purposes of this economic evaluation, the forms were initially
usedinarelatedstudyfundedbytheNationalInstituteofHealth
Research (NIHR) research for patient benefit programme
“assessing the impact of a new birth centre on choice and
outcome of maternity care in an inner city area,” which will be
reported in full elsewhere, comparing the costs of care in a free
standing midwifery unit with care in an obstetric unit in the
same trust.
16 The data collected included details of staffing
levels, treatments, surgeries, diagnostic imaging tests, scans,
drugs, and other resource inputs associated with each stage of
thepathwaythroughintrapartumandafterbirthcare.Interviews
with senior midwives from different geographical regions in
England were then conducted to standardise the supplemental
resource profiles.
Unit cost estimation
Unit cost estimation involved a combination of bottom-up and
top-down costing methods and followed guidance on costing
healthcare services as part of an economic evaluation.
15 17
Detailed unit costs, derived from the finance departments of
participating trusts and information provided by senior
midwives,wereestimatedforresourceinputsintothefollowing
components of intrapartum and after birth care for all settings:
homebirth delivery packs; NHS reimbursement for midwifery
travel;someformsofpainrelief;alternativemodesofdelivery;
active management of the third stage of labour; suturing for
episiotomy; suturing third and fourth degree perineal tears;
manual removal of the placenta; blood transfusions; and care
afterastillbirthorneonataldeath.Unitoverheadswereestimated
through the same finance departments for all settings and
coveredmanagementandadministrativecosts,operationalcosts
(includingheatingandlighting,training,buildingmaintenance),
indirectoverheads(includingpersonnelandfinancefunctions),
and capital costs based on the new build and land requirements
of NHS facilities, accounting for unit occupancy rates. These
data were used to generate an overheads cost per place of birth
per hour. Midwifery staffing and attributable on-costs, with the
additionofcontributionstotheClinicalNegligenceSchemefor
Trust (CNST), were derived from national sources and were
weighted for length of labour care for all planned places of
birth.
18 19 These midwifery costs were considered to be a major
costdriveracrossallsettingsforbirthandwereallocateddirectly
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RESEARCHDefinitions of key variables
• Adverse perinatal outcome: a composite of perinatal mortality and specified neonatal morbidities: stillbirth after the start of care in
labour, early neonatal death, neonatal encephalopathy, meconium aspiration syndrome, brachial plexus injury, fractured humerus, or
fractured clavicle
• Adverse maternal morbidity: defined as at least one of: general anaesthetic; instrumental birth; caesarean section; third or fourth
degree perineal trauma; blood transfusion; admission to an intensive treatment unit, high dependency unit, or specialist unit; or maternal
death (within 42 days after giving birth)
• Normal birth: defined by the Maternity Care Working Party
14 as birth without any of: induction of labour; epidural or spinal analgesia;
general anaesthetic; episiotomy; forceps, ventouse, or caesarean section
• Complicating conditions identified at the start of care in labour: prolonged rupture of membranes (>18 hours), meconium stained liquor,
proteinuria (1+ or more), hypertension, abnormal vaginal bleeding, non-cephalic presentation, abnormal fetal heart rate, or other
complications.
to the duration (hours) of the labour episode per woman. This
includedthemidpointsalaryforaband6or7midwife,including
salaryon-costs,directandindirectoverheads,andcontributions
to qualifications, adjusted for working hours a week and study
and leave days. Drug costs were supplemented with data from
the British National Formulary, number 61.
20 Similarly, the
costs of medical supplies were supplemented with data from
the NHS Supply Chain Catalogue, April 2009 version.
21 Costs
per day for each level of neonatal care, as well as high
dependencyorintensivecareforthemother,werederivedfrom
nationalreferencecostsfromtheDepartmentofHealth.
22Costs
of emergency and non-emergency transfers were derived from
secondary sources but weighted by individual level data on
duration and mode of transport.
22 All unit costs in this study
were expressed in pounds sterling (£) and valued at 2009-10
prices.
Cost effectiveness analytical methods
We estimated differences in resource use and costs with the
independent samples t test procedure and differences in effects
with odds ratios and weighted incidence rates from the cohort
study.Costeffectivenesswasexpressedasincrementalcostper
adverse perinatal outcome avoided, per maternal morbidity
avoided, and per additional “normal birth.” For reasons
explained in the cohort study report, obstetric units contained
more women in whom complicating conditions were an
unexpected observation, which suggests that the risk profile of
low risk women varied between the settings. To ensure that
women we compared had comparable risk status, we repeated
all of these analyses for low risk women without complicating
conditions at the start of care in labour (see box for the list of
complicating conditions).
12 13 We used non-parametric
bootstrapping, involving 1000 bias corrected replications of
each of the incremental cost effectiveness ratios, to calculate
uncertaintyaroundallcosteffectivenessestimates.
23 24Thiswas
represented on four quadrant cost effectiveness planes. Though
cost effectiveness estimates were weighted, neither costs nor
effects were adjusted for potential confounders in the baseline
analyses. Weighting accounted for each unit’s duration of
participation in the study and took into account the clustered
nature of the data within the cohort study. Probability weights
were incorporated in the analysis to adjust for the probability
of selection of each woman. The weight applied to each
observation was inversely proportional to the probability of
selection of the unit and the duration of data collection in that
unit. The weights were recalculated for each bootstrapped
sample. Decision uncertainty was examined by estimating net
benefitstatisticsandconstructingcosteffectivenessacceptability
curvesacrosscosteffectivenessthresholdvaluesofbetween£0
and £100 000 for the health outcomes of interest.
In a series of subgroup analyses we repeated all analyses by
parity subgroup for the primary cost effectiveness
outcome—namely, incremental cost per adverse perinatal
outcome avoided. In addition, we undertook a series of
sensitivity analyses to explore the implications of uncertainty
surrounding key drivers of cost in intrapartum care and the
variables for which there was the most uncertainty surrounding
the resource use parameters. These included varying the
overheads, occupancy rates, and staffing costs attributed to the
duration of labour care. We recalculated the incremental cost
effectiveness ratios after these sensitivity analyses.
We used multiple regression to estimate the differences in total
cost between the settings for birth and to adjust for potential
confounders, including maternal age, parity, ethnicity,
understandingofEnglish,maritalstatus,BMI,indexofmultiple
deprivation score, parity, and gestational age at birth, which
could each be associated with planned place of birth and with
adverse outcomes.
12 For the generalised linear model on costs,
we selected a γ distribution and identity link function in
preferencetoalternativedistributionalformsandlinkfunctions
on the basis of its low Akaike’s information criterion (AIC)
statistic. All analyses were performed with Stata version 11,
SPSS version 17 (SPSS, Chicago, IL), and Microsoft Excel
(Microsoft, Seattle, WA) 2010 software.
Results
The cohort study recruited 79 774 eligible women, 64 538 of
whom were at low risk of complications before the onset of
labour. The women were recruited from 142 of 147 trusts
providinghomebirthservices,53of56freestandingmidwifery
units, 43 of 51 alongside midwifery units, and a stratified
random sample of 36 of 180 obstetric units. Analyses reported
indetailelsewhere
12foundthat,overall,therewerenosignificant
differencesintheoddsofadverseperinataloutcomeforplanned
births in any of the non- obstetric unit settings compared with
the obstetric units. Complicating conditions identified at the
start of care in labour, however, were more common among
low risk women in the planned obstetric unit group, suggesting
that the groups were not homogeneous with regard to risk. In
further analyses restricted to women without complicating
conditions at the start of care in labour, the adjusted odds of
adverse perinatal outcomes were higher for births planned at
home compared with those planned in obstetric units (adjusted
odds ratio 1.59, 95% confidence interval 1.01 to 2.52). In the
restricted analyses, we did not find an increase in adverse
perinatal outcomes for births planned in either free standing
midwiferyunitsoralongsidemidwiferyunits.Subgroupanalyses
by parity showed a significantly increased adjusted odds of
adverse perinatal outcome for nulliparous women for births
plannedathomecomparedwiththoseplannedinobstetricunits
(1.75, 1.07 to 2.86); the strength of this association increased
among women without complicating conditions at the start of
care in labour (2.80, 1.59 to 4.92). The adjusted odds of the
secondary maternal outcomes—namely, maternal morbidity
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RESEARCHavoided and “normal birth”—were significantly increased for
planned births in all three non-obstetric unit settings compared
with those planned in obstetric units. Further details on the
characteristics of the recruited women, and their clinical and
safety outcomes, are reported in the cohort paper and the fuller
report.
12 13
Profilesofresourceuse,andtheirassociatedunitcosts,foreach
planned place of birth are reported in detail in appendices 1 and
2 on bmj.com.
25 The total mean costs per low risk woman
planningbirthinthevarioussettingsatthestartofcareinlabour
were£1631(€1950,$2603)foranobstetricunit,£1461(€1747,
$2332) for an alongside midwifery unit, £1435 (€1715, $2290)
for a free standing midwifery unit, and £1067 (€1274, $1701)
for the home (table 1⇓). Unit overheads and staffing costs were
the key drivers of cost in these analyses. Restriction of the
analyses to low risk women without complicating conditions at
thestartofcareinlabournarrowedthecostdifferencesbetween
planned places of birth: total mean costs were £1511 for an
obstetric unit, £1426 for an alongside midwifery unit, £1405
for a free standing midwifery unit, and for £1027 the home
(table 2⇓). The generalised linear model on costs showed that,
even after adjustment for clinical and sociodemographic
confounders, planned birth in settings other than obstetric units
remained cost saving compared with the reference category of
the obstetric unit: savings averaged £134, £130, and £310 for
planned births in alongside midwifery units, free standing
midwifery units, and at home, respectively (P<0.001) (see
appendix 3 on bmj.com). This model also showed that being
multiparousormarriedwasassociatedwithreducedcosts,while
birth after 40 weeks’ gestation, being overweight or obese, and
maternalageof30ormorewereeachassociatedwithincreased
costs.
Table 3⇓ presents incremental cost effectiveness ratios and net
benefit statistics for the primary clinical outcome—namely,
adverse perinatal outcome avoided for low risk women. For all
low risk women, bootstrapped estimates showed that planned
birth in settings other than an obstetric unit was associated with
costsavingsandconsiderablestochasticuncertaintysurrounding
adverse perinatal outcomes. Consequently, for all shifts to
settings other than an obstetric unit from planned birth in
obstetric units, the bootstrapped incremental cost effectiveness
ratiosfellacrossboththesoutheast(representingreducedcosts
and improved outcomes) and south west (representing reduced
costs and worse outcomes) quadrants of the cost effectiveness
plane.
25 Switching from planned birth in an obstetric unit to
home birth was on average cost saving, while the average
increase in adverse perinatal outcomes was not significant.
Switching from planned birth in an obstetric unit to midwifery
units was on average cost saving and associated with a
non-significant decrease in adverse perinatal outcomes.
Differences in perinatal effects were small; however these are
magnified in the incremental cost effectiveness ratio
calculations, as the mean differences in effects are used as the
denominatorsoftheincrementalcosteffectivenessratios.Thus,
the mean incremental cost effectiveness ratios ranged from
−£296 400 to £7 950 356, reflecting sizable reductions in cost
and small changes in perinatal outcome when assessing shifts
from planned birth in obstetric unit to settings other than an
obstetric unit. When the cost effectiveness outcomes were
analysed by parity, planned birth at home in nulliparous low
risk women was associated with significant cost savings and a
significantincreaseinadverseperinataloutcomes;bootstrapped
incremental cost effectiveness ratios largely fell in the south
west quadrant of the cost effectiveness plane (representing, on
average,reducedcostsandworseoutcomes).
25Therewasa0.63
probability of home birth being the most cost effective option
and a 0.35 probability of free standing midwifery units being
the most cost effective option at a £20 000 cost effectiveness
threshold for avoiding an adverse perinatal outcome (fig 1⇓).
This decision uncertainty surrounding the most cost effective
option was not found for place of birth in multiparous low risk
women, on whom planned home birth had a 100% probability
of being the most cost effective option across all cost
effectiveness thresholds between £0 and £100 000 (table 3).⇓
Forlowriskwomenwithoutcomplicatingconditionsatthestart
ofcareinlabour,themeanincrementalcosteffectivenessratios
associated with switches from planned birth in obstetric unit to
non-obstetric unit settings fell in the south west quadrant of the
costeffectivenessplane(representing,onaverage,reducedcosts
andworseoutcomes).
25Themeanincrementalcosteffectiveness
ratios ranged from £143 382 (alongside midwifery units) to
£497 595 (home) (table 4⇓). Planned birth at home in low risk
women without complicating conditions at the start of care in
labour was associated with significant cost savings and a
significant decrease in adverse perinatal outcomes avoided.
Differences in adverse perinatal outcome were not significant
for planned births in midwifery units. When we analysed the
cost effectiveness outcomes by parity, all bootstrapped
incremental cost effectiveness ratios for planned birth at home
innulliparouslowriskwomenwithoutcomplicatingconditions
fell in the south west quadrant of the cost effectiveness plane
(less costly, less effective) (fig 2⇓). At a £20 000 cost
effectiveness threshold for avoiding an adverse perinatal
outcome, there was a 0.80 probability of home birth being the
mostcosteffectiveoptionanda0.16probabilityoffreestanding
midwifery units being the most cost effective option (fig 3⇓).
This decision uncertainty surrounding the most cost effective
option was not found for place of birth in multiparous low risk
women without complicating conditions, in whom planned
home birth had a 100% probability of being the most cost
effectiveoptionacrossallthresholdsofcosteffectiveness(table
4).⇓
When we analysed the effects of planned place of birth on
maternaloutcomes,allshiftstonon-obstetricunitsettingswere
associated with significant cost savings and significant
improvements in terms of maternal morbidity avoided (table
5⇓) or additional normal birth (table 6⇓). This was replicated
for women without complicating conditions at the start of care
in labour. The mean net monetary benefit associated with shifts
to non-obstetric unit settings varied from £2486 (£2259 to
£2692) (alongside midwifery units) to £4498 (£4306 to £4669)
(home) at a £20 000 cost effectiveness threshold for avoiding
a maternal morbidity (table 5⇓), and from £3828 (£3600 to
£4052) (alongside midwifery units) to £6609 (£6411 to £6810)
(home) at a £20 000 cost effectiveness threshold for achieving
an additional normal birth (table 6⇓). Birth at home generated
thegreatestmeannetmonetarybenefitwitha100%probability
of being the optimal setting across all thresholds of cost
effectiveness(variedbetween£0and£100000forthematernal
outcomes of interest).
Finally, sensitivity analyses showed that the mean incremental
costeffectivenessratiosremainedrelativelyrobusttovariations
inoverheadsandstaffingcostsattributedtolabourcarebutwere
sensitive to unit occupancy rates.
25
Discussion
Summary of main findings
In this study of the cost effectiveness of alternative planned
placesofbirthinEnglandinwomenatlowriskofcomplications
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RESEARCHbeforetheonsetoflabour,wefoundthatthecostofintrapartum
and after birth care, and associated related complications, was
less for births planned at home, in a free standing midwifery
unit, or in an alongside midwifery unit compared with planned
births in an obstetric unit. The total mean unadjusted costs per
lowriskwomanbeforetheonsetoflabourvariedbetween£1066
for births planned at home and £1631 for births planned in
obstetric units. Cost differences between alternative planned
placesofbirthnarrowedwhenwerestrictedthestudypopulation
to women without complicating conditions at the start of care
inlabourortonulliparouswomen.Overall,andformultiparous
women, planned birth at home generated the greatest mean net
benefit with a 100% probability of being the optimal setting
across all thresholds of cost effectiveness when perinatal
outcomes were considered. There was, however, an increased
incidenceofadverseperinataloutcomesassociatedwithplanned
birth at home in nulliparous low risk women, resulting in the
probability of it being the most cost effective option at a
thresholdof£20000decliningto0.63.Withregardstomaternal
outcomes, planned birth at home generated the greatest mean
netbenefitwitha100%probabilityofbeingtheoptimalsetting
across all cost effectiveness thresholds.
Strengths and weaknesses
This economic evaluation was based on a rigorously conducted
cohort study of sufficient size to detect clinically important
differences in adverse perinatal outcomes. Other strengths of
the underpinning cohort study include high participation by
midwifery units and trusts in England; the minimisation of
selection bias through achievement of a high response rate and
absence of self selection bias because of non-consent; and the
abilitytocomparegroupsthatweresimilarintermsofidentified
clinical risk.
12 The economic evaluation was conducted
according to nationally agreed design and reporting
guidelines.
15 26Collectionofprimaryunitcostdatawasthorough
and accounted for regional differences in care patterns. We had
a comprehensive strategy for handling uncertainty surrounding
individual parameters and the value of the cost effectiveness
threshold.
The study does have limitations. Firstly, some components of
the unit cost data collection were based on limited returns from
finance departments and had to be modelled with data from
secondary sources.
25 Nevertheless, with the exception of
variations in unit occupancy rates, sensitivity analyses that
varied the values of key cost drivers had little effect on the
results. Secondly, the limited time horizon of the study meant
that the follow-up of outcomes for both mother and baby did
not extend beyond the time period of labour and care
immediately after birth, or higher level postnatal or neonatal
care when this was received. Perinatal events can result in
associated longer term health and broader societal costs, as
shown by the size of damages paid in obstetric litigation cases,
whichrepresentasubstantialcosttotheNHS.
27Follow-upover
weeks or longer to monitor recovery, or a future assessment of
the outcomes for mothers and babies at a later date, would act
as a vehicle for estimating costs and consequences beyond the
perinatal period and shed more light on long term cost
effectiveness. Thirdly, this study used only clinically defined
outcomes to determine the cost effectiveness of planned place
of birth. A broader economic approach to the measurement of
outcomes, such as stated preference discrete choice modelling,
might have captured women’s preferences for alternative
attributes of planned place of birth and might have been more
informative to decision makers,
28 but this was not practically
possible given the anonymity involved in the study design and
the available resources. Fourthly, and related, an attempt to
valueoutcomesintermsofqualityadjustedlifeyears(QALYs)
in preference to clinical endpoints should make the findings of
thiscosteffectivenessresearchmorerelevanttodecisionmakers
for obstetric care in the NHS. The paucity of evidence for the
longer term consequences of adverse events and other health
outcomes after birth for both mother and baby remains and
further research to generate combined QALY estimates for the
linked mother-baby dyad should be a priority for research in
this specialty. Finally, the remit of our research covered only
intrapartum and immediate after birth care. Midwifery units
also provide important aspects of antenatal care and postnatal
care in the community, the cost effectiveness of which was not
examined in our study.
Interpretation
Our economic evaluation broadly supports a policy of choice
of planned place of birth for low risk women. This cost
effectiveness information, however, should be considered in
the light of an increased risk of adverse perinatal outcome
associated with planned home birth in low risk nulliparous
women. Our cost calculations are likely to be susceptible to
changes in unit occupancy rates and relative cost effectiveness
might alter accordingly. Moreover, the analysis presented here
reflects cost effectiveness at the time of the Birthplace national
prospectivecohortstudyandthecontextoftheNHSduringthat
period.Shouldchangestotheconfigurationofmaternityservices
be planned to optimise cost effectiveness, then commissioners
wouldhavetoconsidertheresourceandrelatedcostimplications
for the maternity services as a whole. This would require
comprehensive economic assessments of the opportunity costs
(that is, foregone benefits) associated with investments and
disinvestments in alternative forms of provision of maternity
services; this in turn will probably require economic modelling
and forecasting of occupancy rates, overheads, patients’ safety,
and transfer in view of fixed and variable costs.
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RESEARCHWhat is already known on this topic
Robust evidence on the cost effectiveness of planned birth in alternative settings is lacking
What this study adds
Planned birth at home, in a free standing midwifery unit, or in an alongside midwifery unit generates incremental cost savings compared
with planned birth in an obstetric unit
For nulliparous low risk women, planned birth at home generates incremental cost savings but increases adverse perinatal outcomes
For multiparous low risk women, planned birth at home generates incremental cost savings with no significant effect on adverse perinatal
outcomes
For maternal outcomes, planned birth at home was the most cost effective option
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RESEARCHTables
Table 1| Mean cost (£) per woman according to planned place of birth for all women at low risk of complications (2009-10 prices)
Bootstrap mean difference (95% CI)
P value*
Mean (SE) cost (£)
Cost category
Alongside
midwifery
unit (AMU)
Freestanding
midwifery
unit (FMU) Home
Obstetric
unit (OU) OU−AMU OU−FMU OU−home
−118.7 (−126.9 to
−110.6)
−143.3 (−152.2 to
−134.9)
−475.6 (−482.0 to
−468.8)
<0.001 451 (2.8) 426 (3.1) 93 (1.9) 569 (2.9) Overheads
138.7 (130.4 to 147.2) 105.2 (95.9 to 114.4) 108.1 (100.2 to 116.4) <0.001 611 (3.4) 578 (3.8) 581 (2.8) 472 (2.4) Midwifery staffing
0 0 111.7 (111.2 to 112.1) <0.001 0 0 112 (0.2) 0 (0) Homebirth
resources
0.0036 (0.0034 to
0.0037)
49.1 (46.9 to 51.2) 33.7 (32.4 to 35.1) <0.001 <0.01 (0.0) 49 (1.0) 34 (0.7) 0 (0) Transfers
42.9 (41.8 to 44.2) 36.4 (34.9 to 37.8) 53.0 (51.2 to 54.8) <0.001 43 (0.6) 36 (0.7) 53 (0.9) 0 (0) Procedures after
transfer
−92.9 (−99.2 to −86.6) −113.4 (−119.9 to
−107.2)
−130.1 (−135.8 to
−124.7)
<0.001 114 (1.9) 94 (2.1) 77 (1.5) 207 (2.5) Birth
−89.9 (−94.9 to −85.1) −109.3 (−114.2 to
−104.4)
−122.8 (−127.1 to
−118.2)
<0.001 84 (1.5) 65 (1.7) 50 (1.3) 174 (1.9) Procedures during
labour care
−20.1 (−22.1 to −18.3) 5.1 (2.7 to 7.6) 104.3(−105.9 to
−102.5)
<0.001 102 (0.6) 127 (0.9) 18 (0.4) 122 (0.6) Postnatal care
−9.6 (−11.8 to −7.6) −11.9 (−14.3 to −9.8) −13.2 (−15.5 to −10.8) <0.001 11.8 (0.6) 9 (0.9) 8 (0.8) 22 (0.9) Higher care-mother
−19.6 (−35.6 to −1.9) −15.0 (−32.8to −3.7) −21.9 (−36.6 to −9.4) 0.037 45 (6.2) 50 (7.5) 42 (4.3) 64 (5.2) Admission to higher
care-baby
−169.5 (−199.7 to
−137.4)
−195.4 (129.1 to
−157.4)
−564.6 (−591.7 to
−533.9)
<0.001 1461 (11.1) 1435 (13.5) 1067 (8.9) 1631 (10.1) Total cost
*Estimated though analysis of variance.
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RESEARCHTable 2| Mean cost (£) per woman according to planned place of birth for women at low risk and without complicating conditions at start
of care in labour (2009-10 prices)
Bootstrap mean difference (95% CI)
P value*
Mean (SE) cost (£)
Cost category
Alongside
midwifery
unit (AMU)
Freestanding
midwifery
unit (FMU) Home
Obstetric
unit (OU) OU−AMU OU−FMU OU−home
−103.2 (−115.7 to
−90.2)
−125.2 (−138.8 to
−111.5)
−463.2 (−473.6 to
−453.8)
<0.001 442 (2.8) 420 (3.2) 81 (1.8) 545 (3.1) Overheads
151.1 (136.9 to 165.2) −120.9 (107.7 to
137.6)
121.9.0 (109.8 to
133.3)
<0.001 603 (3.5) 573 (3.9) 574 (2.9) 452 (2.6) Midwifery staffing
0.0 (0.0 to 0.0) 0.0 (0.0 to 0.0) 111.7 (111.2 to 112.1) <0.001 0 (0) 0 (0) 112 (0.2) 0 (0) Homebirth
resources
0.0036 (0.0034 to
0.0037)
46.2 (42.2 to 49.2) 31.6 (29.1 to 33.8) <0.001 <0.01 (0.0) 46 (1.0) 32 (0.7) 0 (0) Transfers
40.2 (38.9 to 41.5) 33.9 (32.5 to 35.4) 49.4 (47.6 to 51.2) <0.001 40 (0.6) 34 (0.7) 49 (0.9) 0 (0) Procedures after
transfer
−67.4 (−76.1 to −56.1) −86.2 (−95.9 to −76.2) −104.4 (−113.3 to
−95.8)
<0.001 108 (1.9) 89 (2.1) 71 (1.5) 175 (2.5) Birth
−71.8 (−78.9 to −63.3) −90.1 (−98.2 to −82.4) −105.3 (−112.7 to
−96.1)
<0.001 80 (1.5) 62 (1.7) 46 (1.2) 152 (2.0) Procedures during
labour care
−14.23 (−17.7 to
−11.7)
11.5 (7.63 to 14.9) −98.8 (−101.3 to
−96.1)
<0.001 100 (0.6) 126 (0.9) 16 (0.4) 114 (0.7) Postnatal care
−7.6 (−10.8 to −4.5) −9.6 (−15.4 to −5.1) −11.3 (−15.3 to −7.6) <0.001 11 (0.6) 9 (0.9) 7 (0.8) 19 (0.9) Admission to higher
care-mother
−11.7 (−27.1 to 20.3) −7.02 (−38.9 to −35.1) −16.9 (−39.5 to 5.5) 0.037 43 (6.4) 47 (7.8) 38 (4.3) 54 (5.8) Admission to higher
care-baby
−84.0 (−114.4 to
−55.2)
−105.1 (−165.4 to
−45.6)
−483.8 (−537.5 to
−435.6)
<0.001 1426 (11.3) 1405 (13.7) 1027 (8.8) 152 (10.1) Total cost
*Estimated though analysis of variance.
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RESEARCHTable 3| Incremental cost effectiveness ratios and net benefit statistics for primary outcome (adverse perinatal outcome avoided) for all
women at low risk of complications according to planned place of birth: home, freestanding midwifery unit (FMU), or alongside midwifery
unit (AMU) with obstetric unit (OU) as reference
AMU FMU Home
All low risk women
−170 (−199 to −141) −196 (−229 to −163) −565 (−591 to −538) Cost difference (95% CI)
0.0005 (−0.0007 to 0.0019) 0.0004 (−0.0010 to 0.0019) −0.00007 (−0.0014 to 0.0013) Difference in adverse perinatal outcome*
avoided (95% CI)
−296 400 −431 873 7 950 356 Mean ICER†
South east South east South west Quadrant on cost effectiveness plane
167 (111 to 224) 263 (211 to 315) 592 (547 to 639) Mean net benefit (95% CI)‡
174 (99 to 244) 270 (205 to 334) 593 (535 to 654) Mean net benefit (95% CI)§
Nulliparous low risk women
−92 (−142 to −33) −163 (−217 to −108) −281 (−343 to −217) Cost difference (95% CI)
0.0005 (−0.003 to 0.003) 0.0008 (−0.002 to 0.003) −0.004 (−0.008 to −0.00001) Difference in adverse perinatal outcome*
avoided (95% CI)
−47995 −98136 69761 Mean ICER†
South east South east South west Quadrant on cost effectiveness plane
103 (9 to 189) 179 (98 to 259) 204 (77 to 319) Mean net benefit (95% CI)‡
110 (−10 to 217) 188 (87 to 289) 165 (−2 to 321) Mean net benefit (95% CI)§
Multiparous low risk women
−151 (−184 to −117) −173 (−208 to −139) −362 (−390 to −335) Cost difference (95% CI)
0.0007 (−0.001 to 0.003) 0.0005 (−0.0015 to 0.0024) 0.001 (−0.0004 to 0.0025) Difference in adverse perinatal outcome*
avoided (95% CI)
−119 618 −128 134 −323 037 Mean ICER†
South east South east South east Quadrant on cost effectiveness plane
165 (115 to 222) 182 (120 to 244) 382 (336 to 427) Mean net benefit (95% CI)‡
172 (108 to 244) 186 (107 to 267) 391 (335 to 451) Mean net benefit (95% CI)§
*Composite of perinatal mortality and specified neonatal morbidities: stillbirth after start of care in labour, early neonatal death, neonatal encephalopathy, meconium
aspiration syndrome, brachial plexus injury, fractured humerus, or fractured clavicle.
†95% CI not provided because bootstrapped replicates of incremental cost effectiveness ratios fell across more than one quadrant of cost effectiveness plane.
‡Estimated at £20 000 cost effectiveness threshold.
§Estimated at £30 000 cost effectiveness threshold.
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RESEARCHTable 4| Incremental cost effectiveness ratios and net benefit statistics for primary outcome (adverse perinatal outcome avoided) in women
without complications at start of care in labour according to planned place of birth: home, freestanding midwifery unit (FMU), or alongside
midwifery unit (AMU) with obstetric unit (OU) as reference
AMU FMU Home
All low risk women without complicating conditions
−84 (−115 to −53) −105 (−139 to −71) −484 (−511 to −456) Cost difference (95% CI)
−0.0005 (−0.0019 to 0.0007) −0.0003 (−0.0017 to 0.0011) −0.0009 (−0.0023 to −0.0003) Difference in adverse perinatal outcome*
avoided (95% CI)
143 382 313 886 497 595 Mean ICER†
South west South west South west Quadrant on cost effectiveness plane
58 (5 to 114) 143 (92 to 193) 483 (434 to 534) Mean net benefit (95% CI)‡
53 (−13 to 121) 140 (74 to 200) 473 (410 to 536) Mean net benefit (95% CI)§
Nulliparous low risk women without complicating conditions
−8 (−61 to 48) −598 (−117 to −3) −222 (−281 to −157) Cost difference (95% CI)
−0.00099 (−0.0041 to 0.0013) −0.001 (−0.004 to 0.0012) −0.006 (−0.011 to −0.002) Difference in adverse perinatal outcome*
avoided (95% CI)
1631† 30 169† 39 178 (16 734 to 103 511) Mean ICER
South west South west South west Quadrant on cost effectiveness plane
−13 (−99 to 64) 35 (−34 to 127) 98 (−35 to 210) Mean net benefit (95% CI)‡
−22 (−138 to 73) 23 (−85 to 135) 38 (−142 to 180) Mean net benefit (95% CI)§
Multiparous low risk women without complicating conditions
−98 (−64 to −132) −124 (−158 to −88) −311 (−340 to −285) Cost difference (95% CI)
−0.00009 (−0.00196 to 0.00162) 0.0003 (−0.0015 to −0.0020) 0.0005 (−0.0008 to 0.0019) Difference in adverse perinatal outcome*
avoided (95% CI)
47222 −92180 −315420 Mean ICER†
South west South east South east Quadrant on cost effectiveness plane
98 (41 to 151) 128 (71 to 183) 321 (271 to 367) Mean net benefit (95% CI)‡
97 (24 to 165) 132 (59 to 200) 327 (262 to 384) Mean net benefit (95% CI)§
*Composite of perinatal mortality and specified neonatal morbidities: stillbirth after start of care in labour, early neonatal death, neonatal encephalopathy, meconium
aspiration syndrome, brachial plexus injury, fractured humerus, or fractured clavicle.
†95% CI not provided because bootstrapped replicates of incremental cost effectiveness ratios fell across more than one quadrant of cost effectiveness plane.
‡Estimated at £20 000 cost effectiveness threshold.
§Estimated at £30 000 cost effectiveness threshold.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2292 doi: 10.1136/bmj.e2292 (Published 19 April 2012) Page 10 of 13
RESEARCHTable 5| Incremental cost effectiveness ratios and net benefit statistics for maternal morbidity avoided in women at low risk of complications
according to planned place of birth: home, freestanding midwifery unit (FMU), or alongside midwifery unit (AMU) with obstetric unit (OU)
as reference
AMU FMU Home
All low risk women
−154 (−190 to −118) −247 (−280 to −211) −590 (−618 to −563) Cost difference (95% CI)
0.116 (0.106 to 0.126) 0.172 (0.168 to 0.182) 0.195 (0.187 to 0.204) Difference in maternal morbidity* avoided
(95% CI)
−1322 (−1572 to −1049) −1442 (−1600 to −1284) −3024 (−3138 to −2912) Mean ICER (95% CI)
South east South east South east Quadrant on cost effectiveness plane
2486 (2259 to 2692) 3683 (3451 to 3904) 4498 (4306 to 4669) Mean net benefit (95% CI)†
3651 (3322 to 3950) 5403 (5068 to 5716) 6451 (6175 to 6705) Mean net benefit (95% CI)§
Low risk women without complicating conditions
−69 (−105 to −36) −150 (−186 to −115) −504 (−535 to −474) Cost difference (95% CI)
0.088 (0.078 to 0.098) 0.139 (0.131 to 0.149) 0.165 (0.156 to 0.174) Difference in maternal morbidity* avoided
(95% CI)
−782 (−1130 to −431) −1075 (−1285 to −843) −3052 (−3215 to −2902) Mean ICER (95% CI)
South east South east South east Quadrant on cost effectiveness plane
1828 (1605 to 2059) 2942 (2743 to 3166) 3808 (3620 to 4012) Mean net benefit (95% CI)†
2706 (2382 to 3040) 4340 (4051 to 4658) 5459 (5181 to 5754) Mean net benefit (95% CI)§
*Defined as at least one of: general anaesthetic; instrumental birth; caesarean section; third or fourth degree perineal trauma; blood transfusion; admission to
intensive treatment unit, high dependency unit, or specialist unit; and maternal death (within 42 days of giving birth). This is composite measure and was also
secondary outcome of interest in cohort study.
†Estimated at £20 000 cost effectiveness threshold.
§Estimated at £30 000 cost effectiveness threshold.
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RESEARCHTable 6| Incremental cost effectiveness ratios and net benefit statistics for normal birth outcome in women at low risk of complications
according to planned place of birth: home, freestanding midwifery unit (FMU), or alongside midwifery unit (AMU) with obstetric unit (OU)
as reference
AMU FMU Home
All low risk women
−154 (−190 to −118) −247 (−280 to −211) −590 (−618 to −563) Cost difference (95% CI)
0.184 (0.173 to 0.194) 0.256 (0.245 to 0.268) 0.300 (0.290 to 0.310) Difference in normal birth* (95% CI)
−836 (−1002 to −664) −956 (−1076 to −847) −1960 (−2034 to −1890) Mean ICER (95% CI)
South east South east South east Quadrant on cost effectiveness plane
3828 (3600 to 4052) 5377 (5133 to 5618) 6609 (6411 to 6810) Mean net benefit (95% CI)†
5663 (5332 to 5992) 7941 (7585 to 8298) 9618 (9334 to 9909) Mean net benefit (95% CI)‡
Low risk women without complicating conditions
−69 (−105 to −36) −150 (−187 to −116) −504 (−535 to −474) Cost difference (95% CI)
0.149 (0.138 to 0.160) 0.218 (0.207 to 0.229) 0.266 (0.256 to 0.275) Difference in normal birth* (95% CI)
−464 (−685 to −254) −689 (−823 to −538) −1897 (−1985 to −1812) Mean ICER (95% CI)
South east South east South east Quadrant on cost effectiveness plane
3042 (2812 to 3307) 4507 (4285 to 4766) 5822 (5612 to 6036) Mean net benefit (95% CI)†
4526 (4188 to 4911) 6688 (6367 to 7057) 8483 (8178 to 8788) Mean net benefit (95% CI)‡
*Normal birth defined by Maternity Care Working Party as birth without any of induction of labour; epidural or spinal analgesia; general anaesthetic; episiotomy;
forceps, ventouse, or caesarean section.
†Estimated at £20 000 cost effectiveness threshold.
‡Estimated at £30 000 cost effectiveness threshold.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2292 doi: 10.1136/bmj.e2292 (Published 19 April 2012) Page 12 of 13
RESEARCHFigures
Fig 1 Cost effectiveness acceptability curves for planned place of birth for all low risk nulliparous women for adverse perinatal
outcome avoided. At all £10 000 intervals, obstetric units were dominated by other settings and were found to have zero
probability of cost effectiveness
Fig 2 Cost effectiveness plane: planned birth at home compared with planned birth in obstetric units for nulliparous low risk
women without complicating conditions at start of care in labour
Fig 3 Cost effectiveness acceptability curves for planned place of birth for nulliparous low risk women without complicating
conditions at start of care in labour for adverse perinatal outcome avoided
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